Belluscura (FRA:9VQ) Operating Cash Flow per Share : €-0.07 (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Operating Cash Flow per Share?

Belluscura's operating cash flow per share for the six months ended in Jun. 2023 was €-0.03. Belluscura's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.07.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -136.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Belluscura's Operating Cash Flow per Share or its related term are showing as below:

FRA:9VQ' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -136.8 Med: -89.05 Max: -41.3
Current: -136.8

During the past 5 years, Belluscura's highest 3-Year average Operating Cash Flow per Share Growth Rate was -41.30% per year. The lowest was -136.80% per year. And the median was -89.05% per year.

FRA:9VQ's 3-Year OCF Growth Rate is ranked worse than
98.98% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs FRA:9VQ: -136.80

Belluscura Operating Cash Flow per Share Historical Data

The historical data trend for Belluscura's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Operating Cash Flow per Share Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

-0.02

-0.01

-0.06

-0.11

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-0.03	-0.03	-0.07	-0.04	-0.03

Competitive Comparison of Belluscura's Operating Cash Flow per Share

For the Medical Devices subindustry, Belluscura's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Belluscura's Price-to-Operating-Cash-Flow falls into.

Belluscura Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Belluscura's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-14.071	/	131.797
	=	-0.11

Belluscura's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-4.513	/	136.358
	=	-0.03

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.07

Belluscura Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Belluscura's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines